Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients von Saridaki, Zacharenia, Tzardi, Maria, Papadaki, Chara, Sfakianaki, Maria, Pega, Fraga, Kalikaki, Aristea, Tsakalaki, Eleftheria, Trypaki, Maria, Messaritakis, Ippokratis, Stathopoulos, Efstathios, Mavroudis, Dimitris, Georgoulias, Vassilis, Souglakos, John

Volltext

Tumoral Expression of TXR1 and TSP1 Predicts Overall Survival of Patients with Lung Adenocarcinoma Treated with First-line Docetaxel-Gemcitabine Regimen von PAPADAKI, Chara, MAVROUDIS, Dimitris, TRYPAKI, Maria, KOUTSOPOULOS, Anastasios, STATHOPOULOS, Efstathios, HATZIDAKI, Dora, TSAKALAKI, Eleftheria, GEORGOULIAS, Vassilis, SOUGLAKOS, John

Volltext

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients von Saridaki, Zacharenia, Tzardi, Maria, Papadaki, Chara, Sfakianaki, Maria, Pega, Fraga, Kalikaki, Aristea, Tsakalaki, Eleftheria, Trypaki, Maria, Messaritakis, Ippokratis, Stathopoulos, Efstathios, Mavroudis, Dimitris, Georgoulias, Vassilis, Souglakos, John

Volltext

LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer von Lagoudaki, Eleni D, Koutsopoulos, Anastasios V, Sfakianaki, Maria, Papadaki, Chara, Manikis, Georgios C, Voutsina, Alexandra, Trypaki, Maria, Tsakalaki, Eleftheria, Fiolitaki, Georgia, Hatzidaki, Dora, Yiachnakis, Emmanuel, Koumaki, Dimitra, Mavroudis, Dimitrios, Tzardi, Maria, Stathopoulos, Efstathios N, Marias, Kostas, Georgoulias, Vassilis, Souglakos, John

Volltext

Pkm2 Expression Could Predict Resistance to Oxaliplatin Combination Chemotherapy in Patients with Stage Ii/Iii or Metastatic Colorectal Cancer von Saridaki, Zacharenia, Papadaki, Chara, Tzardi, Maria, Sfakianaki, Maria, Sfakiotaki, Georgia, Giagas, George, Messaritakis, Ippokratis, Tsakalaki, Eleftheria, Trypaki, Maria, Mavroudis, Demitris, Georgoulias, Vassilis, Souglakos, John

Volltext

PKM2 mRNA expression to predict disease recurrence in patients with stage II or III colon cancer treated with oxaliplatin in combination with fluoropyrimidines von Papadaki, Chara, Sfakianaki, Maria, Saridaki, Zacharenia, Giagas, Georgios, Mpananis, Kyriakos, Tzardi, Maria, Tsakalaki, Eleftheria, Trypaki, Maria, Georgoulias, Vassilis, Sougklakos, Ioannis

Volltext

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in [greater than or equal to]2.sup.nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients von Saridaki, Zacharenia, Tzardi, Maria, Papadaki, Chara, Sfakianaki, Maria, Pega, Fraga, Kalikaki, Aristea, Tsakalaki, Eleftheria, Trypaki, Maria, Messaritakis, Ippokratis, Stathopoulos, Efstathios, Mavroudis, Dimitris, Georgoulias, Vassilis, Souglakos, John

Volltext

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in greater than or equal to 2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients von Saridaki, Zacharenia, Tzardi, Maria, Papadaki, Chara, Sfakianaki, Maria, Pega, Fraga, Kalikaki, Aristea, Tsakalaki, Eleftheria, Trypaki, Maria, Messaritakis, Ippokratis, Stathopoulos, Efstathios, Mavroudis, Dimitris, Georgoulias, Vassilis, Souglakos, John

Volltext